新闻|股票|评论|外汇|债券|基金|期货|黄金|银行|保险|数据|行情|信托|理财|区块链|汽车|房产|科技|视频|博客
|直播|财道
|农金

简称:复星医药 代码:600196


会计年度:2021-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计39,005,086,602.4120,228,269,452.6218,776,817,149.7948.14
医疗健康服务4,118,000,000.003,333,000,000.00785,000,000.0019.06
医疗器械与医学诊断5,938,000,000.003,042,000,000.002,896,000,000.0048.77
制药28,904,000,000.0013,840,000,000.0015,064,000,000.0052.12

会计年度:2021-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计16,952,397,688.868,110,877,794.068,841,519,894.8052.15
医疗健康服务1,844,000,000.001,511,000,000.00333,000,000.0018.06
医疗器械与医学诊断2,837,000,000.001,480,000,000.001,357,000,000.0047.83
制药12,248,000,000.005,107,000,000.007,141,000,000.0058.30

会计年度:2020-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计30,306,981,264.1713,431,177,923.0016,875,803,341.1755.68
医疗服务3,172,000,000.002,521,000,000.00651,000,000.0020.52
医疗器械与医学诊断5,217,000,000.002,473,000,000.002,744,000,000.0052.60
制药21,880,000,000.008,414,000,000.0013,466,000,000.0061.54

会计年度:2020-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计14,028,164,572.106,215,871,656.337,812,292,915.7755.69
药品制造与研发10,011,904,300.003,754,050,900.006,257,853,400.0062.50
医疗服务1,359,866,500.001,130,367,900.00229,498,600.0016.88
医疗器械与医学诊断2,641,017,100.001,308,813,000.001,332,204,100.0050.44

会计年度:2019-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计28,585,152,033.18------
平衡项目43,544,433.18------
药品制造与研发21,765,873,400.007,478,841,900.0014,287,031,500.0065.64
医疗服务3,039,922,700.002,264,073,100.00775,849,600.0025.52
医疗器械与医学诊断3,735,811,500.001,779,042,500.001,956,769,000.0052.38

    1/9 转到